Be an Active Part of the Conversation

This informal poster session is designed to help you connect with peers in a relaxed and collaborative setting. This is the perfect space to continue conversations started during the day and build new relationships with others advancing iPSC derived therapies.

With a highly focused biopharma audience actively engaged in preclinical development, manufacturing, and clinical translation, this is your opportunity to share your work and get meaningful feedback from those who understand the challenges first hand. Don’t miss out on the chance to connect, learn, and present.

Why present a poster?

  • Share your perspective and experience in a fast moving iPSC landscape
  • Increase visibility for your research, platform, or approach
  • Engage in thoughtful, peer to peer discussion and receive direct feedback
  • Spark conversations that can lead to collaboration, partnerships, or fresh insight
Viewing poster
poster session socialising
Explaining poster

How to Submit Your Poster

  • You must first register your place to attend the 6th iPSC Drug Development Summit
  • Submit an abstract for review to showcase your poster during the Scientific Poster Session
  • You will be notified once your abstract has been accepted along with details of printing and size requirements. We do request an online PDF of the poster 2 weeks prior to the summit
  • Abstract Submission Deadline: August 26, 2026
  • Scientific Poster Session: September 9, 2026

T&Cs

  • Posters should not be used for sales and marketing purposes
  • If your company offers pay-for services, you will need to submit your poster request to our partnerships team - sponsor@hansonwade.com
  • All abstracts are subject to approval by the conference organizers, who reserve the right to reject submissions

Explore the Full Event Guide

  • 25+ Industry leading speakers
  • End-to-end coverage of iPSC drug development
  • 2 dedicated tracks on preclinical development and process development and CMC
  • Unrivaled Networking Opportunities with Clinical Companies Securing Investment
  • See why this is the must-attend meeting for iPSC development
ee7 brochure image (7)